ADIPOQ and metabolic syndrome: They reported an AUC of 0.71 (CI 95%: 0.62–0.79, P < 0.05) for the HOMA-Adiponectin and of 0.68 (CI 95%: 0.59–0.76, P < 0.01) for the HOMA-IR, and concluded that HOMA-Adiponectin is an adequate tool for determining insulin resistance among obese children with metabolic syndrome.